Sarda Proteins Ltd. has officially closed its trading window for designated employees and their relatives. This measure took effect on April 1, 2026.
The closure is a standard procedure required by SEBI (Prohibition of Insider Trading) Regulations. Its purpose is to prevent individuals with access to non-public, price-sensitive information from trading company shares before the audited financial results for the fiscal year ending March 31, 2026, are publicly announced.
Trading activities by these designated individuals and their relatives are now prohibited. The window is scheduled to reopen 48 hours following the official announcement of the company's audited financial results, ensuring a clear period for market analysis.
Investors will be looking to the upcoming Board meeting where the audited results will be approved. The subsequent announcement will provide the latest financial figures and performance details for FY26.
